Copyright
©2006 Baishideng Publishing Group Co.
World J Gastroenterol. Oct 14, 2006; 12(38): 6182-6187
Published online Oct 14, 2006. doi: 10.3748/wjg.v12.i38.6182
Published online Oct 14, 2006. doi: 10.3748/wjg.v12.i38.6182
Table 1 Immunohistochemistry of VEGF pathway components in intestinal stromal tumours, n (%)
| n | VEGF | VEGFR-1 | VEGFR-2 | ||||
| - | + | - | + | - | + | ||
| GISTs | 33 | 7 (21.2) | 26 (78.8) | 9 (27.3) | 24 (72.7) | 3 (9.1) | 30 (90.9) b |
| Leiomyoma | 15 | 6 (40.0) | 9 (60.0) | 3 (20.0) | 12 (80.0) | 10 (66.7) | 5 (33.3) |
| Schwannoma | 6 | 3 (50.0) | 3 (50.0) | 2 (33.3) | 4 (66.7) | 2 (33.3) | 4 (66.7) |
- Citation: Nakayama T, Cho YC, Mine Y, Yoshizaki A, Naito S, Wen CY, Sekine I. Expression of vascular endothelial growth factor and its receptors VEGFR-1 and 2 in gastrointestinal stromal tumors, leiomyomas and schwannomas. World J Gastroenterol 2006; 12(38): 6182-6187
- URL: https://www.wjgnet.com/1007-9327/full/v12/i38/6182.htm
- DOI: https://dx.doi.org/10.3748/wjg.v12.i38.6182